Annual Use Limitations For Prilosec 1 Should Appear In Labeling – NDAC/GDAC
This article was originally published in The Tan Sheet
Executive Summary
Labeling for Prilosec 1 should advise patients not to take the product for more than two or three 14-day courses per year, the Nonprescription and Gastrointestinal Drugs Advisory Committees said
You may also be interested in...
Prilosec OTC Approved In 28-, 42-Count Multiple Regimen Sizes
FDA's June 20 approval of Procter & Gamble/ AstraZeneca's Prilosec OTC permits the companies to sell the proton pump inhibitor in packages containing more than one 14-day treatment regimen
Prilosec OTC Approved In 28-, 42-Count Multiple Regimen Sizes
FDA's June 20 approval of Procter & Gamble/ AstraZeneca's Prilosec OTC permits the companies to sell the proton pump inhibitor in packages containing more than one 14-day treatment regimen
Prilosec OTC Approved In 28-, 42-Count Multiple Regimen Sizes
FDA's June 20 approval of Procter & Gamble/ AstraZeneca's Prilosec OTC permits the companies to sell the proton pump inhibitor in packages containing more than one 14-day treatment regimen